2nd Quarter - Report
THE MCMANUS GROUP for ELI LILLY AND COMPANY
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R. 5629, "Pathway for Biosimilars Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Medicare/Medicaid MMM
H.R. 2184, "Enhanced Health Care Value for All Act of 2007," comparative effectiveness provisions. H.R. 2083, "Drug and Medical Device Company Gift Disclosure Act," all provisions. Opposition to increased Medicaid rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.